Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Improve Your Ketosis Detection

Published: Wednesday, August 15, 2012
Last Updated: Wednesday, August 15, 2012
Bookmark and Share
The ß-Hydroxybutyrate LiquiColor® reagent system provides better quantitative results.

Stanbio Laboratory, an EKF Diagnostics company, has developed the ß-Hydroxybutyrate LiquiColor® Reagent System to improve the detection of clinically significant ketosis.

Ketosis is elevated levels of ketones in the body that occur when stored fats are broken down in response to a low supply of energy (glucose). Using the reagent system, levels of the ketone ß-Hydroxybutyrate in serum and plasma can be used to clinically diagnose and monitor diabetes mellitus, alcoholism, glycogen storage disease, high fat/low carbohydrate diets, pregnancy, alkalosis, ingestion of isopropyl alcohol, and salicylate poisoning.

As ß-Hydroxybutyrate is the main ketone produced during ketosis (~78%), the blood assay provides a better tool than the nitroprusside test strips commonly used for the detection of ketone bodies in urine, which only detect 22% of ketones present.

ß-Hydroxybutyrate also demonstrates excellent stability, making it the most reliable indicator of clinically relevant ketosis and ketoacidosis.

Stanbio Laboratory’s ß-Hydroxybutyrate LiquiColor® Reagent System produces quantitative and objective results and provides an excellent tool for differentiating metabolic acidosis and monitoring therapy. Its precise and sensitive quantitative results enable earlier detection of ketosis and faster patient treatment, thus improving Emergency Room (ER) and Critical Decision Unit (CDU) throughput and efficiency.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EKF Signs Exclusive Licensing Agreement for Novel Kidney Markers
Accurate early predictors of end stage renal disease developed by Joslin Diabetes Center - Harvard Medical School Affiliate.
Wednesday, August 15, 2012
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos